N-acetylcysteine infusion improves hepatic perfusion in the early stages of systemic sclerosis

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 3, 2009, Pages 763-772

  Rosato, E ^a   Zardi, E M ^b   Barbano, B ^a   Menghi, G ^a   Cianci, R ^a   Amoroso, A ^a   Afeltra, A ^b   Pisarri, S ^a   Salsano, Felice ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Color Doppler sonography; Hepatic flow volume; N acetylcysteine; Portal flow volume; Systemic sclerosis

Indexed keywords

ACETYLCYSTEINE;

ADULT; ARTICLE; CAPILLAROSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HUMAN; LIVER PERFUSION; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

ACETYLCYSTEINE; ADULT; CAPILLARIES; FEMALE; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRAVENOUS; LIVER CIRCULATION; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; PORTAL VEIN; PULSATILE FLOW; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 70350545643     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200322     Document Type: Article

References (32)

1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998; 15: 202-205
2. Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C. Antioxidative and clinical effects of high-dose n-acetylcysteine in fibrosing alveolitis: adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156:1897-1901 (Pubitemid 28011799)
3. Merla A, Romani GL, Di Luzio S, Di Donato L, Farina G, Proietti M, Pisarri S, Salsano F. Raynaud's phenomenon: Infrared functional imaging applied to diagnosis and drug effects. Int J Immunopathol Pharmacol 2002; 15:41-52. (Pubitemid 34285708)
4. Sambo P, Amico D, Giacomelli R, Matucci-Cerinic M, Salsano F, Valentini G, Gabrielli A. Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. J Rheumatol 2001; 28:2257-2262 (Pubitemid 32947872)
5. Brunet J, Boily MJ, Cordeau S, Des Rosiers C. Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow. Free Radic Biol Med 1995; 19:627-638
6. Salsano F, Letizia C, Proietti M, Rossi C, Proietti AR, Rosato E, Pisarri S. Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-Acetylcysteine long term treatment of patients with sclerodermic Raynaud's phenomenon. Int J Immunopathol Pharmacol 2005; 18:761-770
7. Grant PR, Black A, Garcia N, Prieto J, Garson JA. Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study. J Med Virol 2000; 61:439-442 (Pubitemid 30450684)
8. Taut FJ, Breitkreutz R, Zapletal CM, Thies JC, Babylon A, Martin E, Dröge W. Influence of N-acetylcysteine on hepatic amino acid metabolism in patients undergoing orthotopic liver transplantation. Transpl Int 2001; 14:329-333 (Pubitemid 33021063)
9. Fusai G, Glantzounis GK, Hafez T, et al. N-Acetylcysteine ameliorates the late phase of liver ischemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci 2005; 109:465-473
10. Yang YY, Lee KC, Huang YT, Wang YW, Hou MC, Lee FY, Lin HC, Lee SD. Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. J Hepatol 2008; 49:25-33.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Dignostic and Therapeutic Criteria Committee. Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-590
12. Moriyasu F, Nishida O, Ban N, Nakamura T, Sakai M, Miyake T, Uchino H. Congestion index of the portal vein. AJR Am J Roentgenol 1986; 146:735-739
13. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27:155-160 (Pubitemid 30058643)
14. Clements P, Lachenbruch P, Seibold J, White B, Weiner S, Martin R, et al. Inter- and intraobserver variability of the total thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22:1281-1285
15. Valentini G, D'Angelo S, Delia Rossa A, Bencivelli W, Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003; 62:904-905
16. Valentini G, Delia Rossa A, Bombardieri S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001; 60:592-598
17. Medsger TA Jr, Silman AJ, Steen VD, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26:2159-2167
18. Zardi EM, Picardi A, Ambrosino G, Fazio VM, Dobrina A, Frego M, Afeltra A, Lumachi F. Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. In Vivo 2006; 20:377-380 (Pubitemid 43772673)
19. Sambo P, Jannino L, Candela M, Salvi A, Donini M, Dusi S, Luchetti MM, Gabrielli A. Monocytes of patients with systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion. J Invest Dermatol 1999; 112:78-84.
20. Cracowski JL, Marpeau C, Carpentier PH, Imbert B, Hunt M, Stanke-Labesque F, Bessard G. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. Arthritis Rheum 2001; 44:1143-1148 (Pubitemid 32433621)
21. Yamamoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 1998; 25:314-317 (Pubitemid 28088261)
22. Cotton SA, Herrick AL, Jayson MI, Freemont AJ. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol 1999; 189:273-278
23. Dooley A, Gao B, Bradley N, Abraham DJ, Black CM, Jacobs M, Bruckdorfer KR. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology (Oxford) 2006; 45: 676-684 (Pubitemid 43985335)
24. Shi-Wen X, Chen Y, Denton CP, et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 2004; 15:2707-2719 (Pubitemid 38691860)
25. Shi-Wen X, Rodriguez-Pascual F, Lamas S, et al. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol Cell Biol 2006; 26:5518-5527 (Pubitemid 44036217)
26. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44:2653-2664 (Pubitemid 33049343)
27. Hanson KM, Johnson PC. Local control of hepatic arterial and portal venous flow in the dog. Am J Physiol 1966; 211:712-720
28. Ezzat WR, Lautt WW. Hepatic arterial pressure-flow autoregulation is adenosine mediated. Am J Physiol 1987; 252:H836-45.
29. Rappaport AM, Schneiderman JH. The function of the hepatic artery. Rev Physiol Biochem Pharmacol 1976; 76:129-175
30. Svegliati-Baroni G, Saccomanno S, van Goor H, Jansen P, Benedetti A, Moshage H. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver 2001; 21:1-12. (Pubitemid 32112013)
31. Carlisle KM, Halliwell M, Read AE, Wells PN. Estimation of total hepatic blood flow by duplex ultrasound. Gut 1992; 33:92-97
32. Jakab F, Ráth Z, Schmal F, Nagy P, Faller J. Changes in hepatic hemodynamics due to primary liver tumours. HPB Surg 1996; 9:245-248 (Pubitemid 26237655)